Lighting the Way to a Cure

  • Financials
  • Patient Library
  • Blog
  • Calendar
FSHD Header Logo
mobile-logo

  • Who We Are
        • About Us
          • History
          • Mission
          • Our Team
          • Financials
        • Our Impact
          • Therapeutic Accelerator
          • Education
          • Advocacy
          • Our Partners
        • Journey To A Cure
          • 2022 Donor Impact Report
  • Understanding FSHD
        • What is FSHD
          • Symptoms
          • Diagnosis
          • Early-onset FSHD
          • Genetic Testing
        • Living with FSHD
          • Newly Diagnosed?
          • Finding Care
          • Symptom Management
          • Patient Library
        • FSHD University
          • Physical Health
          • Wellness
          • Research
  • Get Involved
        • Support Us
          • Ways to Give
          • Become a Torchbearer
          • Raise Awareness
          • Volunteer
          • Fundraise
        • Advance Research
          • What is a Clinical Trial?
          • Your Involvement Matters
          • Current Trials & Studies
        • Connect
          • Find Your Local Chapter
          • Join the Community
          • World FSHD Alliance
          • Online Communities
        • Events
          • Walk & Roll to Cure FSHD
          • Events Calendar
          • FSHD 360 Regional Conferences
          • World FSHD Day
  • Research
        • For Patients & Families
          • Advance Research
          • True Cost of FSHD Study
          • TestFSHD genetic testing
          • Current Trials and Studies
        • For Researchers
          • Apply for a Grant
          • Research We Have Funded
          • Resources
          • Int’l Research Congress
        • For Clinicians
          • FSHD Masterclass
          • ICD-10
        • For Industry
          • Therapeutic Accelerator
          • Clinical Trial Research Network
          • Drug Development Pipeline
          • Voice of the Patient Report
          • Project Mercury
  • News
    • Media Library
    • Blog
      • Living with FSHD
        • Health and Medicine
        • PT and Exercise
        • Tips and Tricks
        • Mental Health
      • FSHD Society News
      • FSHD Research
      • Fundraising & Events
      • Media & PR
    • FSHD Society Radio
    • The FSHD Advocate
  • Search
  • Financials
  • Patient Library
  • Blog
  • Calendar
  • JOIN US
  • Donate
  • JOIN US
  • Donate

Year End Giving

Home / Year End Giving

TIME = LIVES

Year End Giving

Perhaps, as you look out your window, you feel as though the plans and momentum we created last year and at the beginning of 2020 have been put on hold, delayed, or stymied. Let me assure you: We have not stopped, stalled, or stumbled. Because of your continued commitment, we have moved forward in all the areas mentioned below and made expansive gains in engaging the global FSHD community – speaking with one voice, one million strong.

Despite events beyond our control, FSHD does not stop its devastating progression – and neither can we. And although we needed to find new ways of moving forward, to “drift nor lie at anchor” were not options. While circumstances have changed, our timelines have not, because TIME = LIVES. Every day of delay in carrying out our strategy is a day that symptoms worsen, and our loved ones suffer.

 

BECAUSE TIME = LIVES, our families now have access to a comprehensive, cost-effective genetic test through PerkinElmer. Using state-of-the-art technology, and by partnering with FSHD researchers, PerkinElmer has now made its test available for $700 rather than $3,000 (the average cost of the previous test), and is assisting our families with physician referrals, genetic counseling, and insurance submissions. Along with PerkinElmer Genomics, the FSHD Society is working with several other testing facilities and companies to continue to broaden access to testing while accelerating therapeutic development.

End of year 2020

BECAUSE TIME = LIVES, we hosted a virtual workshop with more than 40 researchers, pharmaceutical teams, and contract research organizations on the topic of blood biomarkers and initiated an FSHD Society-funded pilot study to investigate a promising target. We are currently receiving cost estimates for a “milestone-gated” study into the other targets discussed during the workshop and to seek a dependable, blood-based process to identify DUX4 activity – or lack thereof with a therapy – throughout the body.

BECAUSE TIME = LIVES, we have been collaborating with several of the world’s largest patient registries to synergize and/or analyze data sets for a robust natural history study. Additionally, the FSHD Society has funded an artificial intelligence/machine learning process which, if proven viable, could be linked with other registry platforms throughout the world to synthesize data. And recently, the Critical Path Institute, an FDA-funded organization, has offered to standardize data across registry platforms for enhanced studies.

End of year 2020

BECAUSE TIME = LIVES, we hosted only the third all-virtual FDA “Voice of the Patient” Forum, with more than 400 patients and caregivers, along with many pharmaceutical companies and FDA members, which amplified our families’ voices regarding disease burden and acceptable therapeutic thresholds. The “Voice of the Patient Report,” which will be used by the FDA and pharma companies in therapy development and approval, has been finalized and submitted. The significance of this event and report cannot be overstated and could not have occurred without the participation and investment from you
and the FSHD community.

We have now arrived at a critical juncture. The work we have begun and the progress we have achieved require that we commit additional funding and staff time to key projects and research initiatives. Between now and the end of 2020, we need to raise the financial resources necessary to advance these projects and ensure their completion.

Your donations, your support, your commitment to the FSHD Society and to our collective mission ensures that no one need ever face this disease alone.

TIME=LIVES! Give by December 31, 2020, and your gift will be matched up to $500,000, doubling your impact!
Donate Today

“As a patient I am truly grateful to all of you for making this event happen- giving us the forum for the FDA, Pharma, and clinicians to hear the resounding voice of the patients for this rare disease heard.” – Stuart Lai, New York City

“I know this disease really well after taking care of patients for 20 years. However, I was informed and incredibly moved by the panel of the Voice of the Patient Forum.” – Kathryn Wagner, MD PhD, Global Head of Neuromuscular Disorders, Roche Pharmaceuticals

Sign up for Email Alerts

Stay up to date with the latest FSHD news and updates from FSHD Society.

CONNECT WITH US

Proud Member World FSHD Alliance (1)
Footer-Logo-min

General Mailing Address:

75 North Main Street, Suite 1073
Randolph, MA 02368 U.S.A.

Mail Donations to:

FSHD Society
P.O. Box 411617
Boston, MA 02241-1617

(781) 301-6060

  • DONATE
  • Donate
  • Join Us
  • Inclusivity & Equity
  • Privacy Policy
  • Contact Us
  • Glossary Of Scientific Terms
Digital Marketing by